Minimizing the Size of the U.S. Visit Delegation, Difficult for Large Corporations to Accompany... Blue House "Rumors of Postponing the Korea-U.S. Summit Are Completely Untrue"

[Asia Economy Reporter Ryu Jeong-min] The size of the delegation accompanying the South Korea-US summit, which is just over a month away, will be reduced. Meanwhile, the specific schedule and agenda of the summit remain unclear, leading to various speculations.


The Blue House announced on the 16th that the South Korea-US summit will be held in Washington DC in late May at the invitation of US President Joe Biden. At that time, the Blue House said it was coordinating the detailed schedule with the US and would disclose specific details once finalized. However, even after a week, neither the date of the summit nor the official agenda has been revealed.


The number of personnel accompanying the president to the US is also expected to be minimized. It seems certain that the delegation will be somewhat smaller than initially planned by the Blue House, but it is unclear whether this is due to US requests. If the delegation is reduced, it will likely be difficult to have a large group of businesspeople accompanying the president for cooperation in areas such as vaccines, semiconductors, and electric vehicle batteries.


[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


A Blue House official said regarding the smaller number of personnel compared to previous US visits, "It is related to the COVID-19 situation." During President Moon Jae-in's visit to the US in June 2017, about 50 businesspeople, including Samsung Electronics Vice Chairman Kwon Oh-hyun, accompanied him to support 'sales diplomacy.'


There are speculations that the reduction of the delegation or the delay in scheduling may indicate difficulties in pre-negotiations between South Korea and the US regarding the agenda to be discussed at the summit.


In particular, skepticism is growing over whether the 'vaccine cooperation' discussion, as mentioned by President Moon, will be set as an agenda item. Concerns have even been raised that if the US maintains a passive stance on vaccine provision, the South Korea-US summit itself could be postponed.



The Blue House stated, "The rumors about postponing the South Korea-US summit are completely untrue."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing